Complete Guide to Vortioxetine Pharmacokinetics
Overview
Vortioxetine is a Antidepressant (Multimodal) used in the Psychiatry therapeutic area. It is indicated for Major Depressive Disorder (MDD). Interactive PK/PD simulator for vortioxetine (Trintellix) based on population pharmacokinetic-pharmacodynamic meta-analysis in MDD patients. Explore exposure-efficacy (MADRS) and exposure-safety (nausea) relationships.
Key Pharmacokinetic Parameters
The following parameters are derived from published PopPK + Emax PK/PD models for Vortioxetine:
| Parameter | Value |
|---|---|
| E0 | -13.2 |
| Ka | 0.14 hr-1 |
| Q F | 23 L/hr |
| EC50 | 24.9 ng/mL |
| Emax | 7.0 MADRS points |
| V2 F | 2900 L |
| V3 F | 670 L |
| t half | ~57 hr |
| CL F EU | 39 L/hr |
| CL F US | 51 L/hr |
| CL F RoW | 38 L/hr |
| pk model | 2-compartment, first-order absorption, linear elimination |
| nausea beta0 | -1.6 |
| nausea beta1 | 0.2 |
Parameters represent typical population estimates from published literature. Individual values may vary.
Dosing & Administration
Vortioxetine is administered via the Oral route. Oral administration involves absorption from the gastrointestinal tract, and bioavailability may be affected by food intake, formulation, and first-pass metabolism.
Dosing recommendations should always follow approved prescribing information. The interactive simulator allows you to explore different dosing scenarios and their impact on drug exposure metrics such as AUC, Cmax, and Ctrough.
Clinical Considerations
In the Psychiatry therapeutic area, for the treatment of Major Depressive Disorder (MDD), understanding the pharmacokinetics of Vortioxetine is essential for dose optimization and therapeutic drug monitoring. Key clinical factors that may affect Vortioxetine pharmacokinetics include:
- •Body weight and body composition
- •Renal and hepatic function
- •Drug-drug interactions and concomitant medications
- •Age, sex, and genetic polymorphisms
Interactive Vortioxetine PK Simulator
Explore Vortioxetine pharmacokinetics interactively. Adjust doses, dosing intervals, and patient covariates to visualize concentration-time profiles in real time.
Frequently Asked Questions
What is the half-life of Vortioxetine?
The elimination half-life of Vortioxetine depends on patient-specific factors. Based on published models, the typical half-life is approximately ~57 hr.
How is Vortioxetine administered?
Vortioxetine is administered via the Oral route. It is indicated for Major Depressive Disorder (MDD). As a Antidepressant (Multimodal), dosing regimens should follow approved prescribing information and clinical guidelines.
What are the key PK parameters of Vortioxetine?
Key pharmacokinetic parameters for Vortioxetine include clearance (CL), volume of distribution (Vd), and elimination half-life. See the PK Parameters section above for specific values from published models.
Can I simulate Vortioxetine dosing scenarios for free?
Yes! PKPDBuilder offers a completely free, interactive Vortioxetine PK simulator based on published pharmacometric models. No login required. Use it to explore different doses, dosing intervals, and patient covariates.
⚠️ Disclaimer
This guide is for research and educational purposes only. It is not intended for clinical decision-making or patient dosing. Parameters are derived from published literature and represent population estimates. Always consult approved prescribing information for clinical use.